Investor profile
Maven Capital Partners has backed 76 European tech companies across 79 funding rounds between 2014 and 2026, joining rounds totalling €324M. Most active in Software and Healthtech. Data as of 7 Aug 2026.
Also recorded as: Maven · Maven Ventures
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Summize | UK | 2 | €52M |
| Laverock Therapeutics | UK | 2 | €23M |
| ProofID | UK | 1 | €18M |
| Chorus Intelligence | UK | 1 | €17M |
| Push Technology | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Summize | Other | €46M | 2026-01 |
| ProofID | Other | €18M | 2022-05 |
| Chorus Intelligence | Other | €17M | 2026-03 |
| Laverock Therapeutics |
| 1 |
| €11M |
| Mojo Mortgages | UK | 1 | €7.8M |
| Biorelate | UK | 1 | €7.5M |
| Hello Heart | Israel | 1 | €7.5M |
| Delio | UK | 1 | €7.5M |
| XR Games | UK | 1 | €7.0M |
| Bright Network | UK | 2 | €6.9M |
| Evove | UK | 1 | €6.4M |
| Nano Interactive | Germany | 1 | €6.1M |
| E-Fundamentals | UK | 1 | €6.0M |
| Approov | UK | 1 | €5.7M |
| Blackdot | UK | 1 | €5.4M |
| Third Space Learning | UK | 1 | €5.1M |
| Carcinotech | UK | 1 | €4.9M |
| Novatus | UK | 1 | €4.7M |
| Relative Insight | UK | 1 | €4.6M |
| Podfather | UK | 1 | €4.0M |
| Contego Fraud Solutions | UK | 1 | €4.0M |
| Gen inCode | UK | 1 | €3.8M |
| Revlifter | UK | 1 | €3.7M |
| Concinnity | UK | 1 | €3.6M |
| Sensoteq | Ireland | 1 | €3.6M |
| NuLink | Sweden | 1 | €3.5M |
| Atterley | UK | 1 | €3.5M |
| QikServe | UK | 1 | €3.5M |
| Drovo | UK | 1 | €3.4M |
| Seed |
| €16M |
| 2023-10 |
| Push Technology | Series A | €11M | 2020-04 |
| Mojo Mortgages | Series A | €7.8M | 2019-01 |
| Laverock Therapeutics | Seed | €7.6M | 2025-06 |
| Biorelate | Series A | €7.5M | 2022-11 |
| Hello Heart | Other | €7.5M | 2018-01 |
| Delio | Other | €7.5M | 2022-03 |
